The US Senate has passed two bipartisan bills aimed at making it easier for pilots and air traffic controllers to seek mental health treatment and understand how medications affect their medical eligibility.
Senators approved the John A. Hauser Mental Health in Aviation Act and the Aviation Medication Transparency Act by unanimous consent. Both measures still require House action before they can reach the president.
The legislation seeks to address lengthy medical reviews and time away from work that can discourage pilots and controllers from disclosing mental health conditions and seeking care.
A 2023 Transportation Department inspector general’s report found that the FAA had comprehensive procedures to evaluate pilots’ psychological health, but that pilots’ reluctance to disclose conditions limited the agency’s ability to address safety risks. The report identified stigma, potential career consequences and fear of financial hardship as barriers to disclosure.
The mental health bill, S. 3257, would give the FAA 18 months after enactment to update medical-certification regulations and guidance to encourage treatment and disclosure. It would also require recurring reviews of the special issuance process, which allows the agency to approve applicants who do not meet standard medical requirements.
Those reviews would consider additional medications and evidence-based treatments, enhanced training for aviation medical examiners and whether appropriately trained examiners should have more authority to issue certificates.
The measure would authorize up to $15 million annually for fiscal years 2026 through 2028 to recruit and train examiners, expand FAA medical-review capacity and reduce certification backlogs. It also calls for public education to reduce stigma and improve awareness of support services.
Within two years of enactment, the FAA would have to implement appropriate recommendations from its 2024 Mental Health and Aviation Medical Clearances Aviation Rulemaking Committee. The agency would have to explain to Congress any decision not to adopt a recommendation.
The Air Line Pilots Association welcomed the Senate action, saying pilots beginning antidepressant treatment can wait more than a year for initial FAA authorization.
“Seeking mental health care should be viewed not as a career risk but as a professional responsibility,” ALPA President Captain Jason Ambrosi said.
The separate medication bill, S. 3258, would require the FAA to publish accessible guidance within one year of enactment covering prescription and over-the-counter medications, conditions for their use and whether additional FAA review is needed.
The information would include medications designated “Do Not Issue” or “Do Not Fly” and, where practicable, minimum periods when aviation personnel must limit or suspend duties while stabilizing on a medication. The guidance would be publicly available and accessible through MedXPress.
The FAA has already made separate changes to some mental health certification procedures. Under its current AME-assisted special issuance pathway for anxiety, depression and related conditions, examiners can renew certificates for eligible applicants after the FAA grants initial authorization. Continuing medical documentation is required, and new symptoms or other concerns must be referred back to the agency.
The mental health legislation is named for John A. Hauser, a University of North Dakota aviation student who died by suicide in October 2021. His parents, Anne Suh and Alan Hauser, have supported efforts to improve access to care for aviation students and professionals.
The House passed its own mental health bill in September 2025. Because the Senate approved a separate, amended measure, further House action is necessary.